T1 Disease 208 220 inflammation
T2 Level 517 526 platelets
T3 Gene 1083 1093 anti-PDL1 
T4 Level 181 185 CTCs
T5 Level 1124 1128 CTCs
T6 Level 125 179 wound sites and interact with circulating tumour cells
T7 CL 94 103 Platelets
T8 Condition 944 950 cancer
T9 Intervention 1136 1147 bloodstream
T10 Species 891 896 mouse
T11 Level 1009 1029 engineered platelets
T12 Protein 1100 1112 surgical bed
T13 Gene 623 641 primary melanomas 
T14 Gene 849 859 anti-PDL1 
T15 Condition 78 84 cancer
T16 Gene 650 688  or triple-negative breast carcinomas 
T18 Protein 770 786 platelet-derived
T19 Gene 420 430 anti-PDL1 
T20 Level 322 331 platelets
T21 Level 167 173 tumour
T22 Species 592 596 mice
T23 Gene 709 719 anti-PDL1 
T24 Condition 538 558 post-surgical tumour
T25 Level 259 265 tumour
T26 Gene 834 858 platelet-bound anti-PDL1
R1 Relation Arg1:T21 Arg2:T4
R2 Relation Arg1:T21 Arg2:T25
